Radiopharmaceuticals Third-Party Logistics Market (2026 to 2035)

Radiopharmaceuticals Third-Party Logistics Market Summary:

The global Radiopharmaceuticals Third-Party Logistics Market size was valued at USD 952.8 million in 2025 and is projected to reach USD 3607.5 million by 2035, expanding at a CAGR of 15.00% from 2026 to 2035. The growth during the forecast period is driven by the increasing demand for nuclear medicine procedures, rising adoption of targeted radiopharmaceutical therapies, expanding production of medical isotopes, growing need for specialized cold chain and time-sensitive logistics, and advancements in regulatory-compliant transportation and tracking technologies.

Radiopharmaceuticals Third-Party Logistics Market Revenue Forecast, 2022–2035 (US$ Million)

Years	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035
Revenue (USD Mn)	663.8	XX	XX	952.8	XX	XX	XX	XX	XX	XX	XX	XX	XX	3607.5

Key Market Takeaways & Insights

• North America Radiopharmaceuticals Third-Party Logistics Market held the largest share of 39.00% of the global market in 2025.
• The Radiopharmaceuticals Third-Party Logistics industry in the Asia Pacific is expected to grow significantly over the forecast period.
• By Type, the Diagnostic Radiopharmaceuticals segment held the largest market share of 35.7% in 2025.
• By Service, the transportation segment is expected to grow the fastest growth rate.
• By Temperature Range, the Ambient segment held the largest market share in 2025.

Market Intelligence Overview (Historical, Current, Forecast):

• 2022 Radiopharmaceuticals Third-Party Logistics Market Size: USD 663.8 Million
• 2025 Radiopharmaceuticals Third-Party Logistics Market Size: USD 952.8 Million
• 2035 Radiopharmaceuticals Third-Party Logistics Market Size: USD 3607.5 Million
• CAGR (2026-2035): 15.00%

Radiopharmaceuticals Third-Party Logistics Market Regional Forecast Analysis, 2026–2035 (US$ Million)

Region

2022

2023

2024

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

2035

North America

XX

XX

XX

371.59

XX

XX

XX

XX

XX

XX

XX

XX

XX

1239.2

Europe

XX

XX

XX

285.84

XX

XX

XX

XX

XX

XX

XX

XX

XX

996.4

Asia Pacific

XX

XX

XX

247.73

XX

XX

XX

XX

XX

XX

XX

XX

XX

1190.8

Middle East & Africa

XX

XX

XX

28.58

XX

XX

XX

XX

XX

XX

XX

XX

XX

106.0

Latin America

XX

XX

XX

19.06

XX

XX

XX

XX

XX

XX

XX

XX

XX

75.1

Radiopharmaceutical Demand Analysis:

• Cancer incidence trends
• Nuclear medicine procedure analysis
• Target patient population assessment
• Diagnostic imaging demand trends

Logistics & Distribution Landscape Overview:

• Cold chain logistics analysis
• Radioisotope transport pathways
• Time-critical delivery adoption trends
• Regulatory-compliant distribution approaches

Radiopharmaceuticals Third-Party Logistics Market Outlook Analysis Conservative, Likely, Optimistic, (US$ Million), 2025–2035

	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035
Conservative	952.8	XX	XX	XX	XX	XX	XX	XX	XX	XX	3263.0
Likely	952.8	XX	XX	XX	XX	XX	XX	XX	XX	XX	3607.5
Optimistic	952.8	XX	XX	XX	XX	XX	XX	XX	XX	XX	5335.3

Market Dynamics:
Market Drivers:

Growing Adoption of Logistics Outsourcing Strengthening Biopharmaceutical Third-Party Logistics Demand

The growing trend of outsourcing logistics is expected to fuel the growth of the biopharmaceutical third-party logistics market. Outsourcing logistics entails hiring a third party to handle all or part of a company's logistical operations. Outsourcing logistics is used in biopharmaceutical third-party logistics to manage the cryogenic supply chain through logistics partners. For example, in February 2024, the Bureau of Transportation Statistics, a US-based part of the Department of Transportation (DOT), reported that for-hire freight shipments increased by 1.8% in December 2023 compared to December 2022, while the Freight Transportation Services Index increased from 136.6 in December 2022 to 139.1 in December 2023. As a result, the growing trend of outsourcing logistics is expected to drive the expansion of the biopharmaceutical third-party logistics industry.

Rising Global Cancer Burden Driving Demand for Biopharmaceutical Third-Party Logistics

The increasing prevalence of cancer worldwide is boosting the use of radiopharmaceuticals for diagnostic imaging and targeted therapies, creating greater demand for specialized biopharmaceutical third-party logistics services. These products often require strict temperature control, rapid transportation, and regulatory compliance to preserve their efficacy and short shelf life. As healthcare providers expand access to advanced oncology treatments, logistics partners play a critical role in ensuring timely and secure distribution. According to the World Health Organization, approximately 35 million new cancer cases are projected globally by 2050, representing a 77% increase compared with 2022. This rising disease burden is expected to accelerate radiopharmaceutical shipments and strengthen demand for reliable third-party logistics solutions.

Market Restraint:

Short Half-Life and Time-Sensitive Distribution Challenges

Many radiopharmaceuticals have extremely short half-lives, requiring rapid production, transportation, and administration before radioactive decay reduces their effectiveness. This creates significant logistical challenges for third-party providers, as even minor delays caused by customs procedures, transportation disruptions, or equipment failures can result in product loss and treatment postponements. Maintaining precise coordination across manufacturers, logistics partners, and healthcare facilities is essential but complex. The need for specialized packaging, continuous monitoring, and strict delivery schedules increases operational costs and limits distribution over long distances, particularly in regions with underdeveloped transportation infrastructure.

Complex Regulatory and Safety Compliance Requirements

Radiopharmaceutical logistics involves handling radioactive materials that are subject to stringent national and international regulations governing transportation, storage, labeling, and disposal. Third-party logistics providers must comply with multiple safety standards while ensuring radiation protection for workers and the public. Differences in regulatory frameworks across countries further complicate cross-border shipments and can lead to delays or additional documentation requirements. Companies must also invest heavily in specialized training, certified facilities, and compliance systems, increasing operational complexity and costs. These challenges can restrict market entry for smaller logistics providers and slow the expansion of global radiopharmaceutical distribution networks.

Market Opportunities:

Expanding Global Trade and Biopharmaceutical Commercialization

The rising globalization of the biopharmaceutical industry presents a major opportunity for the third-party logistics market by increasing the need for efficient, secure, and compliant supply chain solutions. As pharmaceutical and biotechnology companies expand their operations into international and emerging markets, they increasingly rely on specialized logistics providers to manage cross-border transportation, customs clearance, regulatory requirements, and temperature-controlled distribution. The growth of global trade, international clinical trials, and strategic partnerships is further driving demand for advanced 3PL services that ensure timely deliveries and maintain product quality. This expanding global footprint is expected to accelerate investment in specialized logistics infrastructure and strengthen long-term market growth.

Expansion of Theranostics and Precision Medicine

The rapid growth of theranostics and precision medicine is creating a major opportunity for the radiopharmaceutical third-party logistics market. Theranostic agents combine diagnostic imaging with targeted therapy, increasing the need for specialized logistics capable of managing temperature-sensitive and time-critical radioactive products. As healthcare providers adopt personalized cancer treatments and governments invest in nuclear medicine infrastructure, demand for reliable transportation and distribution services is expected to rise. Third-party logistics companies with expertise in cold chain management, regulatory compliance, and rapid delivery can capitalize on this trend by supporting expanding clinical applications and international commercialization of advanced radiopharmaceutical therapies.

Radiopharmaceuticals Third-Party Logistics Market Share Analysis by End Use, 2025 (%)

By End Use	2025
Pharma & Biopharma Companies	33%
CDMOs / CMOs	28%
Research Institutes & CROs	18%
Clinical Facilities	11%
Others	10%

Radiopharmaceuticals Third-Party Logistics Market Segmentations Analysis:

By Service, Warehousing & Storage Holds the Largest Share in the Radiopharmaceuticals Third-Party Logistics Market

The warehousing and storage segment held the largest share in 2025. The dominance is due to the growing demand for specialized storage solutions that meet stringent regulatory standards such as Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP). Advances in warehouse automation, real-time inventory tracking, and temperature-controlled storage systems have increased the market's efficiency and reliability.

The transportation segment is expected to grow the fastest in the coming years. The market is growing due to an increase in clinical trials, international product launches, and demand for faster delivery timelines. Healthcare systems are increasingly relying on efficient transportation services as they strive to provide patients with timely access to critical therapies. The rise of direct-to-patient models and home healthcare exacerbates this need.

By Temperature Range, Ambient Hold the Largest Share in the Market

The ambient segment accounted for the majority of share, with 42.6% in 2025, driven by the growing demand for cost-effective and flexible logistics solutions for radiopharmaceuticals that remain stable at controlled room temperature. Reduced reliance on cold chain infrastructure, increasing shipment volumes, and advancements in protective packaging and regulatory compliance are supporting segment growth, making ambient transportation a practical option for suitable radiopharmaceutical products.

The refrigerated segment is expected to witness significant growth during the forecast period due to the increasing use of temperature-sensitive radiopharmaceuticals requiring strict thermal control. Rising adoption of biologics-based therapies, stronger regulatory focus on cold chain compliance, and advancements in temperature monitoring, insulated packaging, and cooling technologies are further driving demand for refrigerated logistics solutions.

By Radioisotope Half-Life, Short Half-Life Dominate the Radiopharmaceuticals Third-Party Logistics Market

The short half-life segment dominated the market in 2025, driven by the increasing use of diagnostic imaging isotopes such as Technetium-99m and Fluorine-18. Growing demand for rapid, just-in-time delivery, reduced decay losses, and specialized third-party logistics services is supporting segment growth. Advancements in tracking technologies, optimized routing, and expanding nuclear medicine infrastructure further strengthen demand.

The ultra-short half-life segment is projected to register a significant CAGR during the forecast period, fueled by rising adoption of PET imaging and on-site cyclotron production. The need for near-instant delivery, synchronized clinical workflows, and highly coordinated logistics is driving investments in localized manufacturing and dedicated transport networks, supporting precision diagnostics and personalized medicine applications.

By Type, Disease Diagnostic Radiopharmaceuticals Hold the Largest Share in the Market

The diagnostic radiopharmaceuticals segment held the largest market share in 2025, accounting for 35.7% of revenue, driven by the widespread use of PET and SPECT imaging in oncology, cardiology, and neurology. High demand for short-lived isotopes such as Technetium-99m and Fluorine-18, along with expanding diagnostic infrastructure and increasing disease prevalence, continues to boost the need for specialized, time-sensitive logistics services.

The theranostics segment is expected to grow significantly during the forecast period, supported by the rising adoption of personalized medicine and targeted radionuclide therapies. Growing use of radioligand treatments, advancements in molecular imaging, and increasing demand for integrated diagnostic-therapeutic approaches are driving the need for precise, compliant, and just-in-time logistics solutions.

By End-User, Pharma & Biopharma Companies Dominate the Radiopharmaceuticals Third-Party Logistics Market

During the forecast period, the pharma and biopharma companies segment had the highest share, with 32.9% in 2025. Pharmaceutical companies play an important role in driving the market by developing pipelines in nuclear medicine and targeted therapies. The growing trend of outsourcing logistics to reduce capital expenditures and improve operational efficiency is propelling market growth. Furthermore, the requirement for regulatory compliance, specialized handling, and time-sensitive distribution is increasing reliance on experienced 3PL providers. Strategic collaborations and global commercialization efforts are boosting demand for integrated, end-to-end logistics solutions. These factors are expected to drive market growth.

The CDMOs / CMOs segment is expected to grow at the second-fastest rate during the forecast period. CDMOs and CMOs are driving demand in the radiopharmaceutical logistics market as manufacturing and development activities become more outsourced. The growing complexity of radiopharmaceutical production, as well as the need for scalable capabilities, are key drivers of this trend. These businesses rely on specialized 3PL providers to handle distribution, regulatory compliance, and time-sensitive delivery requirements.

Radiopharmaceuticals Third-Party Logistics Market Regional Analysis and Forecast, 2022–2035 (US$ Million)

By Geography	2022	2025	2035
North America	XX	371.59	1239.2
US	XX	344.09	XX
Canada	XX	27.50	XX
Europe	XX	285.84	996.4
Germany	XX	58.60	XX
UK	XX	36.59	XX
France	XX	44.59	XX
Italy	XX	24.58	XX
Spain	XX	23.44	XX
Switzerland	XX	8.86	XX
Netherlands	XX	6.00	XX
Rest of Europe	XX	83.18	XX
Asia Pacific	XX	247.73	1190.8
China	XX	103.80	XX
India	XX	18.83	XX
Japan	XX	39.14	XX
South Korea	XX	35.43	XX
Singapore	XX	8.92	XX
Australia	XX	12.88	XX
Thailand	XX	3.22	XX
Malaysia	XX	6.19	XX
Philippines	XX	4.95	XX
Indonesia	XX	3.96	XX
Rest of Asia Pacific	XX	10.40	XX
Middle East & Africa	XX	28.58	106.0
Saudi Arabia	XX	9.38	XX
United Arab Emirates	XX	7.40	XX
South Africa	XX	4.32	XX
Egypt	XX	2.34	XX
Israel	XX	2.06	XX
Rest of MEA	XX	3.09	XX
Latin America	XX	19.06	75.1
Brazil	XX	6.27	XX
Mexico	XX	4.48	XX
Argentina	XX	2.02	XX
Chile	XX	1.64	XX
Colombia	XX	0.99	XX
Peru	XX	0.82	XX
Rest of LA	XX	2.84	XX

North America Radiopharmaceuticals Third-Party Logistics Market Analysis:

North America Radiopharmaceuticals Third-Party Logistics Market held the largest share of 39.00% of the global market in 2025 and was valued at approximately USD 371.59 million. The regional market is primarily driven by the Increasing radiopharmaceutical production capacity, and strong cold-chain logistics infrastructure.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 North America Radiopharmaceuticals Third-Party Logistics Market Size: USD 371.59 Million
• 2035 North America Radiopharmaceuticals Third-Party Logistics Market Size: USD 1239.2 million
• North America Radiopharmaceuticals Third-Party Logistics CAGR (2026-2033): 12.8%

Drivers

• Rising nuclear medicine procedure volumes

• Growing demand for time-critical isotope delivery

• Expansion of PET and SPECT imaging services

Restraints

• Stringent radioactive transport regulations

• High logistics and compliance costs

• Short shelf life of radiopharmaceuticals

Opportunities

• Rising investment in tracking technologies

• Increasing outsourcing by healthcare facilities

United State Radiopharmaceuticals Third-Party Logistics Market Analysis:

The U.S. accounted for the dominant share within North America and represented approximately 12.6% of the regional market in 2025. The U.S. Radiopharmaceuticals Third-Party Logistics Market was valued at nearly USD 344.09 million, supported by strong pharmaceutical outsourcing trend.

Drivers

• Increasing isotope production investments

• High demand for precision oncology diagnostics

• Expansion of specialized healthcare logistics services

Restraints

• Rising operational and labor expenses

• Limited qualified radioactive material handlers

• Strict safety compliance standards

Opportunities

• Rising demand for last-mile delivery services

• Increasing use of real-time shipment monitoring

• Development of dedicated isotope transport fleets

Canada Radiopharmaceuticals Third-Party Logistics Market Analysis:

Canada represented approximately 14.1% of the North American market in 2025 and was valued at around USD 27.50 million. The market is witnessing steady growth due to expansion of regional isotope supply chains.

Drivers

• Rising demand for cancer imaging procedures

• Growing use of diagnostic radioisotopes

• Increasing healthcare logistics outsourcing

Restraints

• High transportation costs

• Limited specialized logistics providers

• Regulatory approval complexities

Opportunities

• Rising investment in cold-chain systems

• Increasing adoption of digital tracking platforms

Europe Radiopharmaceuticals Third-Party Logistics Market Analysis:

Europe accounted for approximately 30.00% of the global Radiopharmaceuticals Third-Party Logistics Market in 2025 and was valued at nearly USD 285.84 million. The market benefits from rising cancer incidence rates.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Europe Radiopharmaceuticals Third-Party Logistics Market Size: USD 285.84 Million
• 2035 Europe Radiopharmaceuticals Third-Party Logistics Market Size: USD 996.4 million
• Europe Radiopharmaceuticals Third-Party Logistics CAGR (2026-2033): 13.3%

Drivers

• Strong healthcare infrastructure support

• Rising cancer incidence rates

• Growth in cross-border healthcare services

Restraints

• High compliance management costs

• Limited isotope transport capacity

• Short product shelf-life challenges

Opportunities

• Rising use of smart tracking technologies

• Increasing pharmaceutical outsourcing demand

United Kingdom Radiopharmaceuticals Third-Party Logistics Market Analysis

The UK represented approximately 12.5% of the European market in 2025 and was valued at nearly USD 36.59 million. The market is supported by growing demand for rapid deliveries.

Drivers

• Growing nuclear medicine utilization

• Rising cancer diagnostic volumes

• Expanding radiotherapy applications

Restraints

• Regulatory compliance burden

• High transportation expenses

• Workforce shortages in specialized logistics

Opportunities

• Rising investment in logistics automation

• Increasing hospital outsourcing activities

Germany Radiopharmaceuticals Third-Party Logistics Market Analysis

Germany accounted for approximately 14.1% of the European market in 2025 and was valued at around USD 58.60 million. The country remains a key European hub for growing healthcare logistics investments.

Drivers

• Strong nuclear medicine infrastructure

• Expanding radiopharmaceutical manufacturing base

• Rising adoption of precision oncology

Restraints

• High operational expenditure

• Limited trained logistics workforce

• Complex documentation requirements

Opportunities

• Rising demand for therapy isotope transport

• Increasing digital supply chain integration

• Development of specialized logistics hubs

France Radiopharmaceuticals Third-Party Logistics Market Analysis

The France accounts for approximately 13.5% of the European market in 2025 and is valued at nearly USD 44.59 million. The market is supported by increasing isotope demand from hospitals.

Drivers

• Rising adoption of nuclear diagnostics

• Expanding oncology treatment programs

• Growing healthcare logistics outsourcing

Restraints

• High cold-chain operating costs

• Limited transport capacity availability

• Workforce shortages in logistics

Opportunities

• Rising investment in distribution centers

• Increasing cross-border transport demand

Italy Radiopharmaceuticals Third-Party Logistics Market Analysis

Italy accounted for approximately 12.7% of the European market in 2025 and was valued at around USD 24.58 million. The country remains a key European hub for rising demand for isotope transportation.

Drivers

• Growing PET imaging procedures

• Increasing cancer diagnosis rates

• Expansion of healthcare logistics services

Restraints

• High transportation costs

• Limited specialized logistics operators

• Regulatory approval delays

Opportunities

• Rising adoption of tracking technologies

• Increasing radiotherapy distribution needs

• Development of dedicated transport services

Spain Radiopharmaceuticals Third-Party Logistics Market Analysis

The Spain represented approximately 12.4% of the European market in 2025 and was valued at nearly USD 23.44 million. The market is supported by increasing isotope consumption volumes.

Drivers

• Expanding nuclear medicine facilities

• Rising demand for oncology imaging

• Growing healthcare modernization initiatives

Restraints

• High compliance costs

• Complex regulatory procedures

• Distribution delays in remote areas

Opportunities

• Expansion of radiopharmaceutical transport services

• Rising use of digital monitoring tools

• Increasing cross-border delivery activities

Switzerland Radiopharmaceuticals Third-Party Logistics Market Analysis

Switzerland accounted for approximately 13.4% of the European market in 2025 and was valued at around USD 8.86 million. The country remains a increasing isotope shipment volumes.

Drivers

• Advanced healthcare infrastructure

• Growing demand for precision diagnostics

• Expansion of radiopharmaceutical research activities

Restraints

• High logistics operating expenses

• Strict transport regulations

• Limited domestic market size

Opportunities

• Expansion of premium logistics services

• Rising demand for therapy isotope transport

• Increasing pharmaceutical partnerships

Netherlands Radiopharmaceuticals Third-Party Logistics Market Analysis

The Netherlands represented approximately 13.1% of the European market in 2025 and was valued at nearly USD 6.00 million. The market is supported by rising investment in cold-chain networks.

Drivers

• Growing radiopharmaceutical trade volumes

• Expansion of nuclear medicine services

• Increasing demand for rapid deliveries

Restraints

• High compliance and handling costs

• Limited specialized workforce availability

• Capacity limitations during peak periods

Opportunities

• Rising isotope export activities

• Increasing logistics outsourcing demand

Asia Pacific Radiopharmaceuticals Third-Party Logistics Market Analysis

Asia-Pacific accounted for approximately 26.00% of the global market in 2025 valued at nearly USD 247.73 million. Growing pharmaceutical outsourcing activities is significantly contributing to regional growth.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Asia Pacific Radiopharmaceuticals Third-Party Logistics Market Size: USD 247.73 Million
• 2035 Asia Pacific Radiopharmaceuticals Third-Party Logistics Market Size: USD 1190.8 Million
• Asia Pacific Radiopharmaceuticals Third-Party Logistics CAGR (2026-2033): 17.0%

Drivers

• Rising cancer screening programs

• Growing healthcare infrastructure investments

• Increasing isotope demand across hospitals

Restraints

• High transportation costs

• Limited specialized logistics providers

• Radioactive material handling challenges

Opportunities

• Growth in radioligand therapy logistics

• Rising investment in tracking technologies

• Development of healthcare logistics hubs

China Radiopharmaceuticals Third-Party Logistics Market Analysis

China represented approximately 16.5% of the Asia-Pacific market in 2025 valued at around USD 103.80 million. The market is expanding rapidly due to the growing PET-CT installation base.

Drivers

• Increasing hospital logistics outsourcing

• Strong healthcare infrastructure expansion

• Growing nuclear medicine investments

Restraints

• Complex radioactive transport approvals

• Regional logistics infrastructure gaps

• High compliance management costs

Opportunities

• Expansion of isotope distribution centers

• Growth in therapy isotope logistics

• Adoption of digital shipment tracking

India Radiopharmaceuticals Third-Party Logistics Market Analysis:

India accounted for approximately 18.9% of the Asia-Pacific market in 2025 valued at nearly USD 18.83 million. Increasing oncology patient volume is driving market expansion across the country.

Drivers

• Rising nuclear medicine procedures

• Expanding radiopharmacy networks

• Increasing oncology patient volume

Restraints

• Limited cold-chain reach in rural areas

• Regulatory documentation burden

• Shortage of specialized transport providers

Opportunities

• Development of regional logistics hubs

• Expansion of radioligand therapy supply chains

• Growth in healthcare logistics outsourcing

Japan Radiopharmaceuticals Third-Party Logistics Market Analysis

Japan represented approximately 15.5% of the Asia-Pacific market in 2025 valued at around USD 39.14 million. The market is characterized by expansion of precision medicine programs.

Drivers

• Advanced nuclear medicine ecosystem

• Growing elderly patient population

• High demand for diagnostic imaging

Restraints

• High transportation operating costs

• Strict radioactive handling regulations

• Workforce shortages in logistics

Opportunities

• Growth in automated logistics systems

• Expansion of therapy isotope transport

• Investment in smart distribution technologies

South Korea Radiopharmaceuticals Third-Party Logistics Market Analysis

South Korea represented approximately 16.1% of the Asia-Pacific market in 2025 and was valued at around USD 35.43 million. The market is expanding rapidly due to increasing radiotherapy applications.

Drivers

• Increasing nuclear imaging adoption

• Expanding biotechnology sector

• Rising cancer screening initiatives

Restraints

• High compliance costs

• Limited specialized logistics operators

• Regulatory approval complexities

Opportunities

• Expansion of cross-border isotope delivery

• Growth in real-time logistics monitoring

• Development of healthcare logistics platforms

Singapore Radiopharmaceuticals Third-Party Logistics Market Analysis:

Singapore accounted for approximately 17.3% of the Asia-Pacific market in 2025 valued at nearly USD 8.92 million. Increasing clinical research activities is driving market expansion across the country.

Drivers

• Growing radiopharmaceutical imports

• Strong healthcare investments

• Increasing clinical research activities

Restraints

• Limited domestic isotope production

• High logistics operating expenses

• Small local market size

Opportunities

• Growth in regional distribution services

• Expansion of premium logistics solutions

Australia Radiopharmaceuticals Third-Party Logistics Market Analysis

Australia represented approximately 16.3% of the Asia-Pacific market in 2025 and was valued at around USD 12.88 million. The market is characterized by rising cancer diagnostic procedures.

Drivers

• Growing healthcare outsourcing trends

• Increasing isotope demand from hospitals

• Strong healthcare infrastructure

Restraints

• Geographic distribution challenges

• High transportation costs

• Limited specialized logistics workforce

Opportunities

• Growth in therapy isotope logistics

• Adoption of advanced tracking platforms

Thailand Radiopharmaceuticals Third-Party Logistics Market Analysis

Thailand represented approximately 17.1% of the Asia-Pacific market in 2025 and was valued at around USD 3.22 million. The market is expanding rapidly due to the rising logistics outsourcing activities.

Drivers

• Growing medical imaging demand

• Expanding oncology treatment services

• Rising healthcare infrastructure investments

Restraints

• Limited isotope transport capacity

• Regulatory compliance hurdles

• Cold-chain infrastructure gaps

Opportunities

• Growth in regional isotope distribution

• Development of temperature-controlled networks

Malaysia Radiopharmaceuticals Third-Party Logistics Market Analysis:

Malaysia accounted for approximately 16.8% of the Asia-Pacific market in 2025 and was valued at nearly USD 6.19 million. Rising oncology treatment volumes is driving market expansion across the country.

Drivers

• Expansion of healthcare logistics services

• Rising oncology treatment volumes

• Government healthcare investments

Restraints

• Limited local isotope production

• High operational expenses

• Regulatory handling requirements

Opportunities

• Expansion of regional logistics hubs

• Growth in radiotherapy supply chains

Philippines Radiopharmaceuticals Third-Party Logistics Market Analysis

Philippines represented approximately 17.2% of the Asia-Pacific market in 2025 and was valued at around USD 4.95 million. The market is characterized by growing logistics outsourcing trend.

Drivers

• Rising cancer diagnosis rates

• Increasing demand for nuclear imaging

• Expansion of hospital infrastructure

Restraints

• Limited cold-chain availability

• High transportation costs

• Dependence on imported isotopes

Opportunities

• Expansion of healthcare distribution networks

• Growth in specialized logistics services

Indonesia Radiopharmaceuticals Third-Party Logistics Market Analysis

Indonesia represented approximately 17.6% of the Asia-Pacific market in 2025 and was valued at around USD 3.96 million. The market is expanding rapidly due to rising food demand; pet care growth; government smart farming focus.

Drivers

• Increasing demand for oncology diagnostics

• Rising radiopharmaceutical imports

• Growth in private healthcare sector

Restraints

• Geographic transportation barriers

• Limited specialized logistics providers

Opportunities

• Growth in cold-chain logistics investments

• Adoption of shipment monitoring technologies

Middle East & Africa Radiopharmaceuticals Third-Party Logistics Market Analysis

Middle East & Africa accounted for approximately 3.00% of the global market in 2025 and was valued at nearly USD 28.58 Million. The market is gradually expanding due to rising nuclear medicine adoption.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Middle East & Africa Radiopharmaceuticals Third-Party Logistics Market Size: USD 28.58 Million
• 2035 Middle East & Africa Radiopharmaceuticals Third-Party Logistics Market Size: USD 106.0 Million
• Middle East & Africa Radiopharmaceuticals Third-Party Logistics CAGR (2026-2033): 14.0%

Drivers

• Increasing isotope import volumes

• Growth in diagnostic imaging centers

• Rising healthcare logistics investments

Restraints

• High radioactive material handling costs

• Regulatory inconsistencies across countries

Opportunities

• Growth in healthcare logistics outsourcing

• Rising investment in cold-chain systems

Saudi Arabia Radiopharmaceuticals Third-Party Logistics Market Analysis:

Saudi Arabia accounted for approximately 14.6% of the Asia-Pacific market in 2025 and was valued at nearly USD 9.38 million. Increasing isotope demand from hospitals is driving market expansion across the country.

Drivers

• Rising cancer screening initiatives

• Growing healthcare modernization programs

Restraints

• High compliance costs

• Limited domestic logistics expertise

Opportunities

• Investment in logistics automation

• Development of healthcare logistics partnerships

United Arab Emirates Radiopharmaceuticals Third-Party Logistics Market Analysis

United Arab Emirates represented approximately 14.9% of the Asia-Pacific market in 2025 and was valued at around USD 7.40 million. The market is characterized by rising healthcare logistics investments.

Drivers

• Advanced healthcare infrastructure development

• Growing diagnostic imaging demand

Restraints

• High transportation expenses

• Strict transport regulations

• Small domestic market size

Opportunities

• Development of specialized transport fleets

• Adoption of digital tracking systems

South Africa Radiopharmaceuticals Third-Party Logistics Market Analysis

South Africa represented approximately 13.8% of the Asia-Pacific market in 2025 and was valued at around USD 4.32 million. The market is expanding rapidly due to rising isotope transportation needs.

Drivers

• Increasing use of nuclear diagnostics

• Expanding healthcare logistics services

Restraints

• High operating costs

• Regulatory compliance challenges

• Limited specialized carriers

Opportunities

• Growth in hospital logistics outsourcing

• Investment in cold-chain facilities

• Adoption of real-time tracking technologies

Egypt Radiopharmaceuticals Third-Party Logistics Market Analysis:

Egypt accounted for approximately 14.2% of the Asia-Pacific market in 2025 and was valued at nearly USD 2.34 million. Growing demand for specialized logistics is driving market expansion across the country.

Drivers

• Growing healthcare infrastructure investments

• Rising cancer diagnostic volumes

• Expanding nuclear medicine services

Restraints

• High logistics costs

• Regulatory complexities

• Dependence on imported isotopes

Opportunities

• Investment in tracking technologies

• Development of specialized logistics centers

Israel Radiopharmaceuticals Third-Party Logistics Market Analysis

Israel represented approximately 14.3% of the Asia-Pacific market in 2025 and was valued at around USD 2.06 million. The market is characterized by strong healthcare innovation investments.

Drivers

• Strong radiopharmaceutical research ecosystem

• Advanced nuclear medicine capabilities

Restraints

• Strict regulatory requirements

• Limited domestic market size

• Capacity constraints for specialized transport

Opportunities

• Growth in international isotope distribution

• Expansion of therapy logistics services

• Adoption of AI-based logistics planning

Latin America Radiopharmaceuticals Third-Party Logistics Market Analysis

Latin America accounted for approximately 2.00% of the global market in 2025 and was valued at around USD 19.06 Million. The market is witnessing gradual growth supported by increasing radiopharmaceutical imports.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Latin America Radiopharmaceuticals Third-Party Logistics Market Size: USD 19.06 Million
• 2035 Latin America Radiopharmaceuticals Third-Party Logistics Market Size: USD 75.1 Million
• Latin America Radiopharmaceuticals Third-Party Logistics CAGR (2026-2033): 14.7%

Drivers

• Rising demand for cancer diagnostics

• Expanding healthcare infrastructure

• Increasing radiopharmaceutical imports

Restraints

• Limited cold-chain infrastructure

• High transportation expenses

• Dependence on imported isotopes

Opportunities

• Expansion of regional logistics networks

• Growth in isotope distribution services

• Rising investment in tracking technologies

Brazil Radiopharmaceuticals Third-Party Logistics Market Analysis:

Brazil accounted for approximately 15.0% of the Asia-Pacific market in 2025 and was valued at nearly USD 6.27 million. Increasing oncology care investments is driving market expansion across the country.

Drivers

• Growing isotope transportation volumes

• Increasing oncology care investments

• Expansion of healthcare logistics services

Restraints

• Infrastructure bottlenecks

• Limited specialized carriers

Opportunities

• Adoption of smart shipment tracking

• Development of healthcare logistics partnerships

Mexico Radiopharmaceuticals Third-Party Logistics Market Analysis:

Mexico accounted for approximately 14.2% of the Asia-Pacific market in 2025 and was valued at nearly USD 4.48 million. Growth in oncology treatment services is driving market expansion across the country.

Drivers

• Rising diagnostic imaging utilization

• Increasing isotope demand

• Expansion of logistics outsourcing

Restraints

• Limited cold-chain reach

• High transport expenses

• Regulatory complexity

Opportunities

• Growth in specialized transport operations

• Adoption of logistics automation

• Development of regional logistics hubs

Argentina Radiopharmaceuticals Third-Party Logistics Market Analysis

Argentina represented approximately 15.2% of the Asia-Pacific market in 2025 and was valued at around USD 2.02 million. The market is characterized by increasing healthcare investments.

Drivers

• Growing hospital logistics requirements

• Increasing healthcare investments

• Strong nuclear medicine presence

Restraints

• High logistics costs

• Regulatory barriers

• Infrastructure limitations

Opportunities

• Expansion of cold-chain infrastructure

• Adoption of digital logistics tools

Chile Radiopharmaceuticals Third-Party Logistics Market Analysis

Chile represented approximately 14.9% of the Asia-Pacific market in 2025 and was valued at around USD 1.64 million. The market is expanding rapidly due to increasing healthcare spending.

Drivers

• Growing diagnostic imaging demand

• Expansion of oncology services

• Rising isotope transportation needs

Restraints

• Small domestic market size

• High handling expenses

• Regulatory compliance burden

Opportunities

• Investment in tracking technologies

• Development of healthcare logistics hubs

Colombia Radiopharmaceuticals Third-Party Logistics Market Analysis:

Colombia accounted for approximately 15.3% of the Asia-Pacific market in 2025 and was valued at nearly USD 0.99 million. Growth in isotope shipment volumes is driving the market growth

Drivers

• Increasing nuclear medicine adoption

• Growing healthcare infrastructure projects

• Rising demand for oncology diagnostics

Restraints

• High operating costs

• Regulatory approval delays

• Limited skilled workforce

Opportunities

• Growth in specialized healthcare transport

• Adoption of digital shipment monitoring

Peru Radiopharmaceuticals Third-Party Logistics Market Analysis

Peru represented approximately 14.6% of the Asia-Pacific market in 2025 and was valued at around USD 0.82 million. The market is characterized by growing healthcare modernization programs.

Drivers

• Rising nuclear diagnostic procedures

• Increasing isotope import demand

• Expansion of oncology care facilities

Restraints

• Geographic transport challenges

• Limited specialized logistics providers

Opportunities

• Investment in tracking platforms

• Development of regional distribution centers

Radiopharmaceuticals Third-Party Logistics Market Key Players: Mention the shareholding of major 5 players

Key Players	Market Share
UPS Healthcare	19.6%
World Courier (Cencora)	17.4%
Life Couriers	12.8%
American Expediting	9.7%
AirNet II LLC	7.9%

UPS Healthcare – 19.6%

UPS Healthcare holds a leading position in the Radiopharmaceuticals Third-Party Logistics Market due to its extensive global cold-chain infrastructure and specialized healthcare logistics network. The company offers time-critical transportation services for radioactive pharmaceuticals, ensuring regulatory compliance and product integrity. Strong international reach, advanced tracking systems, and investments in healthcare logistics facilities continue to strengthen its market share.

World Courier (Cencora) – 17.4%

World Courier is a major player in radiopharmaceutical logistics, supported by its expertise in handling temperature-sensitive and time-critical medical products. The company serves pharmaceutical manufacturers, clinical trials, and healthcare providers worldwide. Its robust global transportation network, specialized compliance capabilities, and focus on high-value healthcare shipments contribute significantly to its strong market position.

Life Couriers – 12.8%

Life Couriers has established a strong presence in the radiopharmaceutical logistics sector through its dedicated medical courier services and expertise in handling sensitive healthcare products. The company specializes in same-day and emergency deliveries, supporting hospitals, imaging centers, and pharmaceutical companies. Its reliability, regulatory compliance, and customized logistics solutions help maintain a significant market share.

American Expediting – 9.7%

American Expediting plays an important role in the market by providing specialized healthcare transportation and supply chain services. The company focuses on urgent and temperature-controlled deliveries for pharmaceutical and radiopharmaceutical products. Strong customer relationships, nationwide service coverage, and investments in real-time shipment monitoring technologies support its growing position in the radiopharmaceutical logistics industry.

AirNet II LLC – 7.9%

AirNet II LLC maintains a notable share in the Radiopharmaceuticals Third-Party Logistics Market through its dedicated air transportation capabilities for time-sensitive medical shipments. The company supports rapid distribution of radiopharmaceuticals to healthcare facilities and diagnostic centers. Its flexible aviation network, focus on reliability, and expertise in critical logistics operations contribute to its competitive market standing.

Radiopharmaceuticals Third-Party Logistics Market Recent Developments

• In April 2025, Life Couriers UK has announced the expansion of its service portfolio to include radiopharmaceutical transportation throughout the UK. This development improves its specialized healthcare logistics capabilities, allowing for the timely delivery of critical treatments used in cancer diagnosis and therapy. The expansion builds on the Life Couriers Group's extensive experience in radiopharmaceutical logistics across Europe and the United States. By expanding its service offering, the company hopes to improve access to time-sensitive therapies while maintaining high standards of operational efficiency, compliance, and patient-centric delivery throughout the UK healthcare system.
• In February 2024, FedEx has announced the opening of its FedEx Life Science Center in India, which will support clinical trial logistics and storage needs for healthcare clients in the Indian market. This center also serves companies shipping healthcare products to India from around the world, offering specialized solutions for handling sensitive life sciences shipments.
• In March 2025, DHL Group, a German logistics and supply chain provider, paid an undisclosed sum for CryoPDP from Cryoport. With this acquisition, DHL hopes to increase its temperature-sensitive logistics capacity, particularly in the life sciences and healthcare sectors, as well as strengthen its ability to serve clients in clinical development and advanced therapy supply chains. CryoPDP is a France-based company that provides white-glove, cold-chain courier services specializing in biopharma, with extensive experience managing GDP-compliant transportation of temperature-sensitive and complex pharmaceutical products.

Radiopharmaceuticals Third-Party Logistics Market Regulatory Framework Analysis:

• Radioactive transport regulations
• Cold-chain compliance standards
• Nuclear safety requirements
• Cross-border logistics oversight

Radiopharmaceuticals Third-Party Logistics Market Patent & IP Landscape

• Radiotracer technology patents
• Isotope handling innovations
• Cold-chain logistics IP trends
• Tracking system developments

Radiopharmaceuticals Third-Party Logistics Market Segmentations:

Our research framework strategically segments the large molecule bioanalytical testing services market by testing methodologies, modality landscape, end-user categories, and key regional markets

By Service

• Transportation
  • Air Freight
  • Road Transport
  • Just-in-Time (JIT) Delivery Services
• Warehousing & Storage
• Packaging Solutions
• Monitoring & Visibility Solutions
• Specialized Handling & Compliance Services
• Others

By Temperature Range

• Ambient
• Controlled Room Temperature (CRT)
• Refrigerated
• Others

By Radioisotope Half-Life

• Ultra-Short Half-Life
• Short Half-Life
• Medium/Long Half-Life

By Type

• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
• Theranostics

By End User

• Pharma & Biopharma Companies
• Research Institutes & CROs
• CDMOs / CMOs
• Clinical Facilities
• Others

By Region & Country

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Rest of EU

Asia Pacific

• China
• India
• Japan
• Australia
• South Korea
• Thailand
• Rest of APAC

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Rest of MEA

Latin America

• Brazil
• Argentina
• Mexico
• Rest of LA

Top Players

• Life Couriers
• UPS
• World Courier (Cencora)
• American Expediting
• AirNet II LLC
• GTA Air Inc.
• Lab Carriers
• Kalitta Charters
• NAF Pharma
• PHSE S.r.l.
• Others

Key Report Attributes	Details
Years Considered	2022 to 2035
Market Size 2025	USD 952.8 Million
Market Size 2035	USD 3607.5 Million
Historical CAGR % (Growth rate)	XX from 2022 to 2025
Futuristic CAGR % (Growth rate)	15.00% from 2026 to 2035
Segments Covered	By Service By Temperature Range By Radioisotope Half-Life By Type By End User
Regions Covered	North America Europe Asia Pacific Middle East & Africa Latin America
Countries Covered	U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Switzerland, Netherlands, Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Singapore; Australia; Australia; Philippines; Indonesia; Brazil; Argentina; Indonesia; Chile; Colombia; Peru; South Africa; Egypt; Israel; Saudi Arabia; UAE; Kuwait
Competitive Landscape Overview	Life Couriers UPS World Courier (Cencora) American Expediting AirNet II LLC GTA Air Inc. Lab Carriers Kalitta Charters NAF Pharma PHSE S.r.l. Others
Flexible Report Customization	The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights.
Data Sources	Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more.

Related Report

Radiopharmaceuticals Market